Humana's Medicare enrollment slid 24 percent last year, to 3.4 million, while its commercial enrollment fell 6 percent to roughly the same amount.
"Despite the impact of the recession on our commercial enrollment levels and medical cost trends, earnings per share increased as we significantly improved results in the consumer segment, controlled administrative costs and implemented successful capital management initiatives," said Angela F. Braly, WellPoint 's president and chief executive officer.
The data used in our present analysis included US commercial enrollment and pharmacy files from the period covering January 2006 through December 2014.
Further, since the people included in this study were those with commercial health insurance enrollment, the observed prevalence may be different than among people who may have different access to health services, such as those without health insurance, or other forms of insurance, such as government-sponsored Medicare or Medicaid plans.
Nationally, enrollment at commercial degree-granting schools grew 147percentt between 1995 and 2002, the most recent numbers available, to nearly 600,000 students.
Analyses were conducted using MarketScan® and Optum US commercial pharmacy claims and enrollment data.
For the commercial population, breaks in enrollment in the source database are typically due to shifts in employment or changing coverage such as obtaining Medicare coverage through aging or disability.
A 3-year time horizon was chosen since this is the duration typically of interest to US third-party payers, based on the average length of enrollment in commercial plans.
Many commercial insurers have expanded enrollment via participation in Health Insurance Exchanges in 2014, and will be held increasingly accountable for how health care dollars are spent [ 14], making cost containment and delivery of quality care of critical importance.
To ensure the populations from two databases had similar demographic distributions, we only included members who had 2012 full-year enrollment of commercial based insurances with both medical and pharmacy coverage.
Based on MarketScan commercial pharmacy claims and enrollment data, a significant difference was observed in unadjusted composite adherence rates for SOF and SIM (92.6% for the SOF + SIM cohort vs 89.7% for the SOF + SIM + RBV cohort; P=0.0423) and in adjusted composite adherence rates for SOF and SIM (92.2% for the SOF + SIM cohort vs 88.7% for the SOF + SIM +RBV cohort; P=0.0176) (Table 5).
